Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by KNOX, E G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KNOX, E G
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 Oxford University Press

research-article

Evolution of Rubella Vaccine Policy for the UK

E G KNOX

Department of Social Medicine. University of Birmingham Edgbaston. Birmingham B15 2TJ. UK

The principles of rubella vaccine strategy are reviewed against the background of the current UK progamme of vaccinating female adolescents, and the contrasting North American programme of vaccinating young children of both sexes. The effects of using both systems simultaneously are then considered: in particular the question of supplementing the established UK system with child vaccination. Previous computer-simulation and mathematical models predicted the consequences of this policy change with insufficient precision, so an elaborated model is proposed, developed and described. Its special advantages over the simpler model from which it was developed are that it represents the detailed pattern of subsequent temporal change, and allows for the effects of earlier epidemic patterns, of seasonal variations in transmission rates, of earlier vaccine policies and changing levels of implementation.

Predictions for the current UK programme, unchanged in principle but converging upon target uptake rates, are compared with the effects of introducing a supplementary policy of vaccinating children. Benefits accrue from supplementary child-uptakes greater than about 50%, but the cost effectiveness is poor. In the absence of a commitment to rubella eradication, and provisions for making vaccination compulsory, it should probably not be undertaken.

Received 1 October 1986


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Epidemiol RevHome page
A. J. Vyse, N. J. Gay, J. M. White, M. E. Ramsay, D. W. G. Brown, B. J. Cohen, L. M. Hesketh, P. Morgan-Capner, and E. Miller
Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for Evidence-based Vaccination Policy
Epidemiol. Rev., December 1, 2002; 24(2): 125 - 136.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.